The Patent Finder

Treatment of Spontaneous Preterm Birth (2015)

NX Prenatal Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/US2013/077868, filed Dec 26, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,928,402Treatment of Spontaneous Preterm Birth
In force
 · High confidence
NX Prenatal Inc.In force
High confidence
US 11,835,530Detection of Microparticle-Associated Proteins Associated with Spontaneous Preterm Birth
In force
 · High confidence
NX Prenatal Inc.In force
High confidence
Application 13/797,933Biomarkers of Preterm Birth
Abandoned
Abandoned May 28, 2019
NX Prenatal Inc.AbandonedAbandoned May 28, 2019
Application 18/494,607Detection of Microparticle-Associated Proteins Associated with Spontaneous Preterm Birth
Pending
Not granted
NX Prenatal Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by NX Prenatal Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited